Great news!

We are happy to announce that Bidi Vapor has been granted a stay order by the FDA.

Which means all 11 flavors of the BIDI®️ Stick are now legal to market and distribute as the FDA is currently reviewing the previously released MDO.

error: Alert: Content is protected!

Study on ENDS Satisfaction Among Adult Users Published

Study on ENDS Satisfaction Among Adult Users Published

Clinical study reveals Bidi Vapor’s e-cigarette may be satisfying alternative for adult combustible cigarette smokers.

MELBOURNE, Fla., June 13, 2022 — Bidi Vapor LLC, announced that a study on its premium electronic nicotine delivery system (ENDS) was published in the Harm Reduction Journal.

Results of the study found the company’s self-contained vaping device branded BIDI® Stick, mimicked the blood levels of nicotine when subjects smoked their usual brand of combustible cigarette, potentially providing a satisfying alternative to cigarette smoking.

In the research published initially in November 2021, comparative blood samples revealed a dramatic alignment between combustible cigarettes and BIDI® Sticks (both tobacco and flavored products). Dr. Ian Fearon, the paper’s lead author and renowned, U.K.-based nicotine scientist, concluded, “BIDI® Stick ENDS delivered nicotine to users comparably to their usual brand cigarette and also elicited similar subjective effects such as satisfaction and relief.”

Fearon went further to note the study’s implications: “Thus, the BIDI® Stick ENDS may be a satisfying alternative to cigarettes among current adult smokers, including those that find it difficult to quit or who are not interested in quitting smoking.”

Researchers completed the clinical “pharmacokinetic” or “PK” study in August of this year to assess both the kinetics of nicotine uptake and the subjective experiences in smokers when they used the BIDI® Stick.

The paper, called “A Randomized, Crossover Clinical Study to Assess Nicotine Pharmacokinetics and Subjective Effects of the BIDI® Stick ENDS Compared with Combustible Cigarettes and a Comparator ENDS in Adult Smokers,” described the findings from a study in adult smokers aged 21-65 who smoked at least 10 factory-manufactured cigarettes a day.

The Harm Reduction Journal is an open access, peer-reviewed international journal of original research and scholarship on drug use and its consequences for individuals, communities, and larger populations.

In a U.S. Food and Drug Administration (FDA) media briefing held in March 2018, Mitch Zeller, director of the FDA’s Center for Tobacco Products (CTP), called combustible cigarettes the “deadliest” but “most efficient way to deliver nicotine.” Zeller has gone on to say that e-cigarettes have yet to reach the level of providing the satisfaction smokers want. That time may have come, said officials with the Melbourne, Florida-based vaping company.

“This study shows that the BIDI® Stick can be a meaningful, nicotine delivery alternative for adult smokers aged 21 and older,” said Niraj Patel, president and CEO of Bidi Vapor. “We are submitting this data to FDA as part of our Premarket Tobacco Product Application (PMTA) and believe the scientific evidence supports that the BIDI® Stick is appropriate for the protection of the public health.”

With regards to the equally significant concern of underage vaping, Patel said measures designed to curb youth access are addressing the problem. “We at Bidi Vapor have always employed the strictest youth-access prevention measures and age-verification policies when marketing our products to adults,” he said. “Our focus has always been the needs of the adult smoker while doing everything possible — including halting online sales — to ensure that minors are not able to access our products.

“The science demonstrating the value of quality ENDS products — inclusive of flavors — to help adult smokers who are unable or unwilling to entirely choose non-combustible alternatives is growing, not just here in the United States, but globally,” Patel said. “My hope is that here in the U.S., the FDA continues to evaluate the science and allows the data to drive future decisions. These advances should benefit adult smokers here in America, as well as smokers around the world.”

Bidi Vapor is in active communication with the FDA over the company’s PMTA for its 11 flavor varieties of the BIDI® Stick, including its tobacco and menthol products, Patel said.

ABOUT BIDI VAPOR

Based in Melbourne, Florida, Bidi Vapor maintains a commitment to responsible marketing, supporting age-verification standards and sustainability through its BIDI® Cares recycling program. The Company’s premier device, the BIDI® Stick, is a premium product made with medical-grade components, a UL-certified battery and technology designed to deliver a consistent vaping experience for adult smokers 21 and over. Bidi Vapor is also adamant about strict compliance with all federal, state and local guidelines and regulations. At Bidi Vapor, innovation is key to our mission, with the BIDI® Stick promoting environmental sustainability while providing a unique vaping experience to adult smokers.

For more information, visit www.bidivapor.com.

 

Related Posts

Bidi Vapor Supports Alabama Vape Directory

MELBOURNE, Fla. — With compliance being a core company value, Bidi Vapor, LLC, announced its support of the state of Alabama and the publishing of a directory of compliant ENDS products legal for sale in the state…

Read More »

ADVISORY: We will temporarily stop all sales and shipping of Bidi Vapor products from March 27-31, 2021, due to systems upgrades and tax integration. We will resume regular business operations on April 1, 2021.

Skip to content